Viral Clearance Market size was USD 403.5 Million in 2020 and is expected to register a CAGR of 21.9% during the forecast period.
Viral Clearance Market size was USD 403.5 Million in 2020 and is expected to register a CAGR of 21.9% during the forecast period. Rapid advancements in pharmaceutical and biotechnology sectors, growing global burden of chronic diseases, launch of novel drugs, and increasing investment in the biopharmaceutical sector are key factors expected to drive market revenue growth over the forecast period.
In addition, technological advancements and advancements in nanofiltration, rising funding and financial support for life sciences industry, and growing R&D activities worldwide are some other key factors expected to drive revenue growth of the market.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4001
Viral clearance entails removal of viral contamination from biological products with the application of customized membranes or chromatography. Viral contamination is a common complication of majority human- and animal-derived biopharmaceuticals. Viruses can be accidently introduced into the manufacturing processes of biological products and can originate from cell lines, cell culture media or from equipment. It is imperative to perform viral testing studies and integrate viral clearance methods into manufacturing processes. Viral clearance studies are an important part of process validation and ensuring safety of drugs. Biopharmaceutical manufacturers have devised alternative methods to overcome viral contaminations caused by cell lines or culture media and this is expected to be a key factor driving market revenue growth over the forecast period.
Viral clearance plays a crucial role in development processes for monoclonal antibodies, recombinant proteins, tissue and blood derived products, and medical devices. It is important to recognize which viruses can potentially contaminate a product and enter its manufacturing processes and this has boosted demand for efficient viral-clearance validation processes. This is expected to drive market growth over the forecast period. However, high costs associated and lengthy drug development processes are expected to restrain market growth to a certain extent over the forecast period.
The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage. The report clearly depicts the current global economic landscape and the considerable situation of the healthcare industry. A substantial increase in demand for healthcare services worldwide, rising cases of the SARS-CoV-2 infection, increasing pharmaceutical research & development activities, and new drug pipelines are among the key factors that have driven the global pharma & healthcare industry growth in the recent past. Growing acceptance of telehealth and telemedicine services, rise in government initiatives for COVID-19 vaccine development, and escalating demand for advanced point-of-care diagnostics and home healthcare products have further bolstered the industry growth.
Major Companies in The Market:
Charles River Laboratories International, Inc., WuXi Biologics, Lonza Group, Merck KGaA, Sigma-Aldrich Corporation, Avance Biosciences Inc., BSL BIOSERVICE, Clean Cells, SGS S.A., Texcell, Inc., and Vironova Biosafety.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/viral-clearance-market
Some Key Highlights from the Report:
- Viral removal segment is expected to account for a significant revenue share in the global market over the forecast period owing to increasing research and development activities in biopharmaceutical sector, rising adoption of this method in drug discovery, and development of efficient viral removal procedures.
- Vaccines segment is expected to register rapid revenue CAGR over the forecast period owing to growing global demand for vaccines and therapeutics due to increasing healthcare burden as a result of rising prevalence of chronic and infectious diseases.
- CROs segment is expected to register considerable revenue growth over the forecast period owing to increasing investment by CROs for advanced drug discovery and development platforms and increasing outsourcing by pharmaceuticals and biotechnology companies for drug discovery services.
- North America is expected to account for largest share in the global market in terms of revenue over the forecast period owing to increasing developments in the biopharmaceutical industry, rising private and public funding for stem cell research, increasing demand and production of monoclonal antibodies, and presence of robust healthcare infrastructure in countries in the region.
- In September 2020, Merck announced expansion of its Singapore biosafety testing laboratory services. The services enable customers to carry out viral clearance studies to ensure safety and quality of their drugs is high during clinical development process.
Download Summary @ https://www.reportsanddata.com/download-summary-form/4001
For the purpose of this report, Reports and Data has segmented the global viral clearance market based on method, application, end-use, and region:
Method Outlook (Revenue, USD Million; 2018-2028)
- Viral Removal
- Chromatography
- Nanofiltration
- Precipitation
- Viral Inactivation
- Low pH
- Solvent Detergent Method
- Pasteurization
- Other Viral Inactivation Methods
- Viral Detection
Application Outlook (Revenue, USD Million; 2018-2028)
- Recombinant Proteins
- Blood and Blood Products
- Vaccines
- Other Applications
End-use Outlook (Revenue, USD Million; 2018-2028)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Others
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4001
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data’s:
Compressor Nebulizer Market , By Product Type (Portable Compressor Nebulizer, Bench Top Compressor Nebulizer), By End-use (Home Use, Hospital Use, Emergency Clinics), and By Region Forecast to 2028
Antibody-drug Conjugates (ADCs) Market , By Technology (Cleavable Linker, Non-cleavable Linker, Linker Less, Immunogen Technology, Immunomedics Technology), By Application (Breast Cancer, Lung Cancer, Colon & Rectum Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Skin Cancer), By End-use, and By Region Forecast to 2028
Burn Care Market Size, Share And Industry Analysis By Product Type (Advanced Burn Care Products, Biologics, Traditional Burn Care Products, and Others), By Depth of Burn, By Cause (Thermal Burn, Electrical Burn, Radiation Burn, Chemical Burn, and Friction Burn), By End-Use, and By Region Forecast to 2028
Atropine Market , By Product Type (Injection, Drop, Gel), By Application (Gastrointestinal, Ophthalmology, Others), and By Region Forecast to 2028
Esomeprazole Sodium Market Size, Share And Industry Analysis By Type (Purity: 99%, Purity: Above 99%, and Others), By Dosage (Tablets, Capsules, and Others), By Application (Gastro Oesophageal Reflux Disease, Duodenal Ulcers, and Others), By Distribution Channel, and By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs